Cargando…

Secondary mutations in t(4;11) leukemia patients

Detalles Bibliográficos
Autores principales:	Prelle, C, Bursen, A, Dingermann, T, Marschalek, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677139/ https://www.ncbi.nlm.nih.gov/pubmed/23242105 http://dx.doi.org/10.1038/leu.2012.365

Ejemplares similares

The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11)
por: Wilhelm, Alexander, et al.
Publicado: (2021)

The IRX1/HOXA connection: insights into a novel t(4;11)- specific cancer mechanism
por: Kühn, Alessa, et al.
Publicado: (2016)

The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
por: Külp, Marius, et al.
Publicado: (2022)

The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34(+) cells
por: Prieto, Cristina, et al.
Publicado: (2017)

411 Mrd. €, 11,9 %
por: Kuhn, Joseph
Publicado: (2022)

The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features
por: Ragusa, Denise, et al.
Publicado: (2019)

t(4;11) translocation in hyperdiploid de novo adult acute myeloid leukemia: A case report
por: Zhang, Min-Yu, et al.
Publicado: (2022)

Synthesis of amorpha-4,11-diene from dihydroartemisinic acid
por: Schwertz, Geoffrey, et al.
Publicado: (2019)

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26
por: Perez Botero, J, et al.
Publicado: (2015)

5,5,7,12,14,14-Hexamethyl-1,8-diaza-4,11-diazoniacyclotetradeca-4,11-diene dichloride trihydrate
por: Ismail, Wafiuddin, et al.
Publicado: (2012)

RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
por: Wilkinson, Adam C., et al.
Publicado: (2013)

Do Non-Genomically Encoded Fusion Transcripts Cause Recurrent Chromosomal Translocations?
por: Kowarz, Eric, et al.
Publicado: (2012)

411. Tolerability of Isavuconazole After Posaconazole Toxicity in Leukemia Patients
por: DiPippo, Adam J, et al.
Publicado: (2018)

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?
por: Webersinke, G, et al.
Publicado: (2014)

Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair
por: Castaño, Julio, et al.
Publicado: (2016)

Diagnostic Usefulness of Genomic Breakpoint Analysis of Various Gene Rearrangements in Acute Leukemias: A Perspective of Long Distance- or Long Distance Inverse-PCR-based Approaches
por: Yang, John Jeongseok, et al.
Publicado: (2012)

Molecular methods for genomic analyses of variant PML-RARA or other RARA-related chromosomal translocations in acute promyelocytic leukemia
por: Kim, Min Jin, et al.
Publicado: (2012)

(4R,11R)-9-(1-hydroxypropan-2-yl)-4,11-diphenyl-1,3,5,7,9-pentaazatricyclo[5.3.1.0(4,11)]undecane-2,6-dithione
por: Wang, Meng, et al.
Publicado: (2011)

Silencing amorpha-4,11-diene synthase Genes in Artemisia annua Leads to FPP Accumulation
por: Catania, Theresa M., et al.
Publicado: (2018)

PHL4/411: Getting Practice on the Internet
por: G. Neville, R, et al.
Publicado: (1999)

4,11-Diaza-1,8-diazoniacyclotetradecane dichloride hemihydrate
por: Kim, Nam-Ho, et al.
Publicado: (2009)

Amorpha-4,11-diene synthase: a key enzyme in artemisinin biosynthesis and engineering
por: Huang, Jin Quan, et al.
Publicado: (2021)

BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
por: Chen, Cunte, et al.
Publicado: (2023)

Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups
por: Riva, L, et al.
Publicado: (2013)

Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates HOXA9 Gene Expression in t(4;11) Leukemia Cells
por: Fioretti, Tiziana, et al.
Publicado: (2021)

Dicentric (7;12)(p11;p11) in T/Myeloid Mixed-Phenotype Acute Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2021)

MLL-Rearranged Acute Leukemia with t(4;11)(q21;q23)—Current Treatment Options. Is There a Role for CAR-T Cell Therapy?
por: Britten, Oliver, et al.
Publicado: (2019)

Catalysis of amorpha-4,11-diene synthase unraveled and improved by mutability landscape guided engineering
por: Abdallah, Ingy I., et al.
Publicado: (2018)

Correction to: Amorpha-4,11-diene synthase: a key enzyme in artemisinin biosynthesis and engineering
por: Huang, Jin Quan, et al.
Publicado: (2021)

Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells
por: Eberle, Irina, et al.
Publicado: (2010)

Pathogenetic, Clinical, and Prognostic Features of Adult t(4;11)(q21;q23)/MLL-AF4 Positive B-Cell Acute Lymphoblastic Leukemia
por: Marchesi, F., et al.
Publicado: (2011)

Novel splicing-factor mutations in juvenile myelomonocytic leukemia
por: Takita, J, et al.
Publicado: (2012)

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
por: Laborde, R R, et al.
Publicado: (2013)

Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial
por: Larrayoz, M, et al.
Publicado: (2017)

Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
por: Park, Sang Hyuk, et al.
Publicado: (2012)

APOBEC3 signature mutations in chronic lymphocytic leukemia
por: Rebhandl, S, et al.
Publicado: (2014)

Acute promyelocytic leukemia with an unusual presentation of secondary postpartum hemorrhage
por: Sharma, Sunita, et al.
Publicado: (2013)

Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?
por: Gao, Jiapei, et al.
Publicado: (2023)

Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia
por: in 't Hout, Florentien E. M., et al.
Publicado: (2020)

Pulmonary Embolism Secondary to Intravenous Immunoglobulin in a Child with Leukemia
por: Seren Oğuz, Işıl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hd8qvm3i5b8qat7chus818miag